EICHORCondition: NASH - Nonalcoholic Steatohepatitis · Sponsor: Perspectum
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
This description comes directly from the study's public registry record.
Cayden Beyer · 01865655343 · cayden.beyer@perspectum.com
Always discuss trial participation with your own doctor first.
| Arizona Liver Health | Chandler, Arizona, United States | Recruiting |
| RUSH University Medical Center | Chicago, Illinois, United States | Recruiting |
| Indiana University Health | Indianapolis, Indiana, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | Recruiting |
| Liver Center of Texas | Dallas, Texas, United States | Active Not Recruiting |
| University of Virginia | Charlottesville, Virginia, United States | Recruiting |
| Virginia Common wealth University | Richmond, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04054310